2 immobilized on gold a positively charged metallopeptide mimic of a section of the gp41 coiled coil containing a hydrophobic pocket suitable for small molecule binding. We demonstrate that the resulting sensor is able to transmit a current in the presence of negatively charged redox marker ions, therefore acting as an artificial ion channel. The electrochemical signal, measured by cyclic voltammetry, was modulated by specific analyte binding to the coiled coil. Nanomolar quantities of peptides and small molecules that bind in the hydrophobic pocket could be selectively detected, providing a method for label-free detection of binding to gp41.
KEYWORDS
HIV-1 gp41, metallopeptide, ion channel sensor, biosensor, cyclic voltammetry, fusion inhibitors, surface plasmon resonance MAIN TEXT: Biosensors have been widely applied in various fields for analyte detection due to their simplicity, high sensitivity and potential ability for real-time and on-site analysis. The typical biosensor is tailored for detection of a specific analyte, often using optical or electrochemical transduction systems [1] [2] [3] . Application of biosensors in the pharmaceutical arena is growing 4, 5 with the goal of achieving high throughput screening of combinatorial libraries for label-free detection of new drugs. A biosensor for this application should be able to discriminate between multiple analytes, ideally ranking them by binding affinity.
In this paper we demonstrate an artificial ion channel biosensor for specific detection of inhibitors that bind to the N-terminal coiled coil domain of the glycoprotein gp41 of Human Immunodeficiency
Virus Type 1 (HIV-1). The gp41 coiled coil is an important target for entry inhibitors that are able to prevent fusion of viral and host cell membranes 6 . During fusion, a conformational rearrangement of gp41 exposes the trimeric coiled coil domain, prior to the formation of a six-helix bundle (6-HB) with three antiparallel C-terminal helices of gp41 [7] [8] [9] . The existing approved drug against HIV fusion is a peptide derived from the C-terminal helix and pre-transmembrane region, Enfuvirtide® (T20), which 3 has high potency but poor bioavailability 10 . Methods to identify low molecular weight fusion inhibitors include screening for compounds that bind to the coiled coil domain, potentially inhibiting six-helix bundle formation [11] [12] [13] [14] . Current screening methods include cell-based fusion and infectivity assays 15, 16 , an ELISA assay for the 6-HB 14 and fluorescence intensity 17 or polarization 18 assays that are able to quantitatively detect peptide binding, and small molecule binding by competitive inhibition.
We describe the development of an artificial ion channel sensor for label-free direct detection of binding to gp41. Artificial ion channel sensors (ICS) consist of an electrode surface modified with a layer of charged biological or synthetic material, and respond to oppositely charged redox marker ions, generating a current when the marker ions are oxidized or reduced at the electrode [19] [20] [21] . The current is caused by electron shuttling through pores in the immobilized layer 21 and can be modulated by interaction of the layer with a specific analyte [22] [23] [24] [25] . Few examples exist of ion channel sensors for protein-protein or protein -small molecule interaction studies 21, 23, 25, 26 , and none to our knowledge in which detection of more than one specific analyte was demonstrated.
We constructed an ICS using a charged gp41 coiled coil complex stabilized by octahedral Fe 2+ coordination to bipyridyl groups at the N-termini of component peptides. A similar construct has been utilized for fluorescence screening to detect small molecule fusion inhibitors binding to the coiled coil 17 .
It contains the residues of a hydrophobic pocket identified as a target for drug binding 27 . We demonstrate use of the ICS for electrochemical detection of peptide and small molecule binding. An equivalent biosensor was elaborated and examined using surface plasmon resonance (SPR) to confirm the electrochemical findings. Both SPR and electrochemical experiments facilitated direct detection of gp41 inhibitors, with the electrochemical experiment having the possibility of much lower instrument cost and relative insensitivity to analyte molecular weight.
Materials and Methods
Reagents Unless otherwise indicated, chemicals were ordered from Sigma-Aldrich (St. 
Results and Discussion
Bioreceptor selection A coiled coil complex was formed from the association of three equivalent gp41 N heptad repeat peptides stabilized by octahedral Fe has the sequence bpy-GQAVEAQQHLLQLTVWGIKQLQARILAVEKK-amide 17,30 . C18-Aib has two α-aminoisobutyric acid residues (B) which promote helical structure 31 . The N-and C-peptide constructs were used as test analytes on the opposing sensors.
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Layer-by-layer assembly of the bioreceptor monitored by CV
The electrochemical biosensors were constructed using layer-by-layer assembly on a gold-plated quartz crystal, as depicted in Scheme 1. The steps in assembly consisted of formation of mixed self-assembled monolayers (SAMs) of alkanethiols (1:1 11-mercaptoundecanoic acid and 6-mercapto-1-hexanol) on gold, EDC/NHS activation of terminal carboxylate groups, PDEA coupling, and disulfide bond formation with the C-terminal cysteine of the peptide. The mercaptohexanol filler was used to reduce non-specific hydrophobic protein binding to the surface 32 , and reduce the density and steric hindrance of the bioreceptors, enabling access of analytes to the binding sites which are midway down the coiled coil. Surface activation was followed by a low pH cysteine wash, to deactivate any uncoupled PDEA on the surface while dislodging non-specifically adsorbed hydrophobic peptide, and a neutral pH Fe 2+ wash, to fully reconstitute the metallopeptide complex and maximize the surface positive charge. The layer-by-layer assembly led to changes in the conductivity of the surface, which could readily be followed by cyclic voltammetry in the presence of biosensor to specific inhibitors was tested by application of increasing concentrations of a known peptide binding partner C18-Aib, and a known non-binder, the scrambled peptide C16-Scr, as shown in Figure 2 . Upon addition of the specific analyte C18-Aib, a stepwise decrease of the observed current through the [Fe(envC) 3 ] 2+ chip was observed, indicating that the analyte impeded the channeling of electrons to and from the electrode by binding onto the bioreceptor on the chip (Figure 2A) . However, the non-specific analyte C16-Scr failed to elicit a CV response, with virtually no change to the CV signal over a wide range of concentrations ( Figure 2B ).
We observed variable maximum current for different chips (eg. see Figure 2 ), which was attributed to the effect of slight differences in the microscopic gold surface or in chip preparation on the channels between adsorbed proteins, to which the ICS is extremely sensitive 21 . Maximum current between chips varied from 60 to 150µA, as shown in the Supplementary Data ( Figure S2 ), which presents the original experimental traces for all analytes measured. The relative change in response with analyte was found to be consistent between chips.
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Since the analyte C18-Aib is negatively charged at neutral pH, and C16-Scr is almost neutral (pI ≅ 6.25) it was necessary to test the impact of analyte charge on the signal modulation, and the specificity and selectivity of the ICS for gp41 inhibitors. This was achieved by testing additional peptides as well as small molecules known to bind to the hydrophobic pocket, together with some known non-binders.
All had been previously screened in a fluorescence binding assay 17 . The positive controls, in addition to peptide C18-Aib, included ADS-J1, a known small molecule hydrophobic pocket binder 35 , and 11{6,11}
and 11{3,5}, two peptidomimetic small molecule inhibitors recently discovered in our lab. The negative controls included an additional scrambled peptide C18-Scr, a peptide in which all hydrophobic groups were replaced by Ala (C16-Ala), and the small molecule peptidomimetic compound 12{7,6,4}
which gave a false positive reading in the fluorescence experiment.
Concentration dependent responses for these analytes were measured by CV and the results are shown in Figure 3 and Table 1 . A clear distinction in biosensor response was observed between positive and negative controls. Importantly, among the series of peptides, only C18-Aib gave a positive response, while scrambled and alanine substituted peptides were negative. One of the scrambled peptides, C18-Scr, has the same pI as C18-Aib, but did not generate a response except at high concentration (> 5µM).
This observation is attributed to non-specific hydrophobic binding to the receptor. In the case of hydrophobic peptide analytes which might have a tendency to aggregate or bind non-specifically, the ICS should be operated at sub-µM analyte concentrations to get a specific response. Of the small molecules 11{6,11}, 11{3,5} and 12{7,6,4}, only the first two gave a positive response. 12{7,6,4} was detected as a false positive in the fluorescence experiment due to interaction between the compound and the fluorescent probe. Any true binding propensity of 12{7,6,4} to the hydrophobic pocket would have been hidden from detection by the fluorescence method, but does not appear to occur.
The data in Figure 3 was fit to obtain IC 50 values according to the equation:
Δi p /i p0 = -c / (1 + (IC 50 /A t ) n ) [1] i p is the cathodic peak current recorded at analyte concentration A t , i p0 is the current in the absence of analyte and Δi p = i p -i p0 . c is a constant representing the dynamic range of the measurement (close to -1), and n is the Hill slope. The IC 50 values obtained are compared with K I values determined from the fluorescence experiment in Table 1 ; the very low receptor concentration (10 11 -10 12 molecules on the surface) would imply that the IC 50 should be equal to the K I 36 . However, for all four specific inhibitors, the IC 50 was found to be less than the K I , by a factor of 2 -3 for three of the inhibitors, and a factor of 10 for ADS-J1. All of the inhibitors are negatively charged at neutral pH, and the effect of analyte charge on the response must be considered 21 . For a negatively charged analyte, suppression of marker ion currents occurs both by occlusion of the pores due to specific binding, and by reduction of the positive charge of the protein layer and hence the concentration of marker ions associated with the surface.
Consequently, the most highly charged analyte, ADS-J1, exhibits the greatest deviation from solution K I and the highest cooperativity of binding, with a Hill slope of 1.
(Supplementary Data).
Regeneration of the ICS Regeneration and reuse of the ion channel biosensor was tested by several rounds of application of a solution of 30nM ADS-J1 followed by 0.125% sodium dodecyl sulfate, as shown in Figure 4 . The response remained consistent over eight repetitions, with cathodic peak currents of 48 ± 3 µA and 64 ± 5 µA for the biosensor in the presence of analyte and after regeneration, respectively. We have not reused or tested the chips past eight cycles. The biosensor was found to be stable for extended periods at 4°C and over a voltage sweep range of 0 -0.5V 37 .
Confirmation of bioreceptor activity by SPR
SPR measurements were used to confirm biosensor preparation and activity. The analogous chip assembly process was followed from the SPR response (Supplementary Data, Table S1) , and analyte responses were tested for both the [Fe(envC The ion channel biosensor measures analyte binding in a direct way, rather than by competitive inhibition, and no labeled C-peptide binding partner is required as in the fluorescence experiment. As demonstrated above, the affinity of negatively charged analytes was overestimated, by a factor that appeared to correlate with analyte pI or pKa. The interaction of inhibitors in the gp41 hydrophobic pocket involves both hydrophobic and electrostatic contacts [38] [39] [40] , and the charge on the inhibitors plays a crucial role in binding 41, 42 . It is impossible to avoid the effect of analyte charge on the ICS response 21 .
We have shown that specific structural interactions are important for determining ICS specificity, and that charge alone is not a sufficient criterion for observation of a response. A negatively charged peptide of the incorrect sequence tests negative. Reasonable values for inhibitor affinity and consistent rank ordering were obtained for partially charged analytes. The discrepancy was larger in the case of a highly charged analyte. By testing ICS response to a wider variety of peptides and small molecules with 11 differing charges, the charge contribution to the response may be elucidated. This is the subject of future work.
Low molecular weight inhibitors can be detected efficiently by ICS compared to SPR, in which accuracy of the detection is generally limited in the case of sensing small molecules. Furthermore, nonspecific hydrophobic associations make SPR measurement of response at saturation difficult.
Maximum response as a function of analyte concentration is necessary for SPR quantification of a µM association. Failure to measure the maximum response can lead to inaccuracies in assessed K d 's. In the ICS, it is easier to estimate the maximum response, which should be close to zero current (Δi p / i p0 = -1)
Conclusions
In summary, we have demonstrated an ion channel biosensor for detection of HIV-1 gp41 inhibitors using electrochemical signal transduction. The sensor was constructed from a section of the gp41 coiled coil domain corresponding to the hydrophobic pocket region, and stabilized in its trimeric form by a metal ion. It was shown to respond specifically to peptides and inhibitors known to bind in the hydrophobic pocket, with a resulting decrease in the current observed in the presence of redox probe Detection of low molecular weight inhibitors and C-peptides which bind to the N-terminal coiled coil of several Class 1 viral fusion domains has been shown to be an effective strategy for identifying viral fusion inhibitors 6 . In many class 1 viruses, the C-peptide is ill-defined in the post-fusion conformation, either due to extended strand structure for the C-terminal domain 43, 44 or an unknown three-dimensional structure. On the other hand, the coiled coil domain is usually recognizable from sequence analysis 45, 46 . Methods. CV scans were carried out in 2 ml of 25 mM Tris-acetate buffer solution (100 mM NaCl, pH 7.0) in the presence of 2 mM K 3 Fe(CN) 6 and 2mM K 4 Fe (CN) 6 . The potential was cycled between 0-0.5 V at a rate of 100 mV s -1 . Table 1 . CV experimental parameters were as described in Figure 1 . Cathodic peak current was measured, and was normalized to display the fractional change with addition of analyte. Analytes 
